On September 10, 2018, the federal Food & Drug Administration (”FDA”) released its revised draft standard Memorandum of Understanding (“MOU”) between states and the FDA addressing the interstate ...
When it comes to medications that are not commercially available, compounding pharmacies play a crucial role in ensuring patients get the treatments they need. Inside the ecosystem of compounding ...
On March 20, 2024, the US Food & Drug Administration (FDA) issued a proposed rule titled Drug Products or Categories of Drug Products that Present Demonstrable Difficulties for Compounding Under ...
Ottawa, Oct. 06, 2023 (GLOBE NEWSWIRE) -- The 503A U.S. compounding pharmacies market revenue is estimated to reach around USD 5,960 million by 2029, according to a study published by Towards ...
DALLAS, August 07, 2025--(BUSINESS WIRE)--AIS Healthcare has been awarded a group purchasing agreement for 503A intrathecal compounded medications with Premier, Inc., effective July 1, 2025. The new ...
Osceola Capital has formed Revelation Pharma Cop, which will focus on acquiring 503A compounding pharmacies. Also, Revelation has acquired Pensacola, Florida-based Everwell Specialty Pharmacy. No ...
(MENAFN- GlobeNewsWire - Nasdaq) This report published by Towards Healthcare, a sister firm of Precedence Research, provides a comprehensive competitive analysis of the U.S. 503A and 503B Compounding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results